NEW YORK (GenomeWeb News) – Genzyme and the National Organization for Rare Disorders (NORD) this week announced the creation of a fund to help patients with mysterious, undiagnosed illnesses.

The fund will be used to help applicants to the National Institutes of Health Undiagnosed Diseases Program, but who are unable to pay for the medical tests required to make them eligible for participation in the program.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Microsoft co-founder Paul Allen also contributed to brain research, NPR reports.

The New York Times reports on the shifting interpretations of what some genetic variants mean over time.

In Cell this week: investigation of metastatic tumor evolution, more than 16,000 genetic variants introduced into the budding yeast model organism, and more.

MIT's Technology Review reports on Genentech's pursuit of personalized cancer vaccines.